Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine vs placebo in irritable bowel syndrome with diarrhea
IRCT20120215009014N544Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Agomelatine with Placebo (2 arms). Started Jan 2025; status: completed.
02
Drugs
agomelatine
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on IRCT20120215009014N544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N544.